Testosterone Cream vs Gel, Injections, Pellets and Oral TRT

Compare the evidence

The topical distinction that generic buying guides miss

In AndroGel 1.62% prescribing information, application is limited to shoulders and upper arms, and the stated minimum before swimming or showering is two hours. In this testosterone gel 1% label, the listed sites include shoulders/upper arms and/or abdomen, with at least five hours before swimming or showering. Both exclude genital application.

These are examples of why the exact label matters, not a universal instruction for every product with the same percentage. The useful comparison records the full product name, concentration, dispenser and label version. A cream prescribed with different instructions must be assessed on its own terms; never transpose a website's scrotal-application suggestion to an approved gel whose label excludes it.

Interpretation limit: Copying an application site or wash interval from a different formulation can change exposure and create avoidable contact risk.

Household transfer is a real decision factor

The boxed warning in AndroGel 1.62% prescribing information addresses secondary exposure, including reported effects in children. Its instructions include handwashing, covering the dry application site and washing the site before anticipated direct skin contact.

Consider who may touch the application area and when: a partner, child, caregiver or contact-sport participant. That is a practical planning question, not a reason to assume topical treatment is always unsuitable. Write down the routine and ask whether the required precautions are realistic. If exposure occurs, follow the product guidance and seek clinical advice rather than dismissing it because the amount seems small.

Interpretation limit: Treating drying as proof that the application site can no longer transfer medicine.

A compounded cream is not automatically an approved gel in another base

The FDA compounding guidance explains that compounded drugs are not FDA-approved and are not reviewed in the same way for safety, effectiveness and quality before marketing. An approved testosterone ingredient or a licensed pharmacy does not make every finished formulation FDA-approved.

Our research checklist asks what product is proposed, why a particular formulation is needed, which pharmacy prepares it, and what evidence supports the expected absorption and follow-up plan. The point is not to declare every compounded preparation ineffective. It is to avoid borrowing confidence from studies of a different formulation or making a dose conversion from a concentration alone.

Interpretation limit: A familiar ingredient name can obscure differences in the actual preparation and supporting evidence.

Injections and pellets trade daily application for different obligations

The Endocrine Society treatment overview describes injection-related discomfort and fluctuating symptoms, and pellet-related procedure concerns such as extrusion, infection or bleeding. It also notes that effects can diminish toward the end of a pellet treatment interval. Neither route promises perfectly constant levels.

Ask how easily the proposed plan can be adjusted, what requires a clinic visit and who handles an unexpected problem. We deliberately do not prescribe a needle, route, frequency or pellet interval here. The comparison should help you obtain the actual training and monitoring plan, not replace it. Storage likewise belongs to the exact dispensed product's instructions.

Interpretation limit: Choosing a less frequent intervention while overlooking procedure risks or a more difficult adjustment when the response is unwanted.

Oral TRT avoids skin transfer, not the need for monitoring

The Kyzatrex prescribing information describes an oral formulation with food-linked use and blood-pressure, red-cell and reproductive precautions. Removing skin application does not establish that all other risks disappear. Read our Kyzatrex, Jatenzo and Tlando comparison for product distinctions.

For each clinically appropriate option, compare five fields: expected benefit, daily burden, household contact burden, monitoring/adjustment process and an itemized cost. Use the two-quote calculator only for arithmetic—not to rank clinical suitability. Missing fees remain unknown, and a lower estimated bill does not establish equal care.

Interpretation limit: Letting a convenience or price advantage substitute for a patient-specific benefit-risk discussion.

Research notebook: concentration, absorption and a blood result are three different things

Source check: September 18, 2026. Original PeakedLabs synthesis; not a new clinical study.

A cream's stated concentration does not answer every quality question

In a 2015 blinded laboratory study, researchers obtained two batches of testosterone preparations from each of ten Toronto compounding pharmacies. Only 50% of pharmacies in the first batch and 30% in the second supplied concentrations within 20% of the prescribed amount; the commercial gel controls were consistent. This was a small, historical, geographically specific product study—not a survey of every pharmacy or compounded cream available today.

Its useful lesson is about verification, not a blanket verdict. The amount in the container, the amount absorbed and the effect on a patient are separate questions. A company cannot establish all three merely by calling its formulation customized. Equally, a concentration problem found in one sample does not prove that a patient's low result comes from a defective product. Ask which evidence supports the specific quality claim and which question the clinician is trying to resolve.

Once daily does not mean perfectly flat throughout the day

A 2015 randomized study of gel-treated older hypogonadal men investigated variability rather than simply asking whether gel raises testosterone. The study enrolled 47 symptomatic men aged at least 65. It found substantial within-person variation; a two-hour outpatient measurement was a poor predictor of another day's average exposure. This does not establish identical variability for every age group or topical product.

That finding corrects a common comparison shortcut: describing gel as having no peaks or troughs while describing injections as inherently unstable. Both the product and the measurement conditions matter. A single result can be useful within a clinician's plan without being a complete picture of every day. The reasonable response to a confusing measurement is to check context and follow the care team's reassessment process—not to increase the application or change the site yourself.

Drying, washing and secondary exposure are different clocks

A product feeling dry is a sensory observation. The label's interval before washing concerns the product's use. Preventing transfer to another person is a household-safety question. Treating these as one interchangeable waiting period can create misleading advice. This is why our comparison names the exact 1% and 1.62% gel examples rather than advertising one universal showering interval for every gel or compounded cream.

Consider a hypothetical parent choosing among clinically suitable routes. The important question is not just whether a topical application fits the morning routine, but whether the household can consistently follow that product's handwashing, covering and contact precautions. Those are questions to resolve with the clinician and pharmacist using the actual patient instructions. A different concentration, application site or compounding base should trigger another check, not the assumption that the previous instructions still apply.

A fair route comparison includes reversibility and the work of treatment

Our proposed comparison worksheet has four columns: what happens on an ordinary treatment day; what happens if the first plan needs adjustment; what is monitored; and what costs are still unknown. This avoids assigning a universal best format. A person who dislikes needles and a person whose household cannot manage topical-contact precautions may reasonably bring different priorities to the same clinical conversation.

The follow-up question is what changing course would involve. Do not confuse a route that requires less daily attention with a route that requires less clinical oversight. Also avoid treating a successful laboratory response as proof that side effects, inconvenience or cost no longer matter. The appropriate tradeoff depends on the actual diagnosis and formulation, not a general ranking of cream, shots or pellets.

The linked oral-treatment article supplies a complementary comparison rather than another version of this page. The calculator estimates user-entered costs; the appointment planner organizes questions. None of those tools determines medical suitability. Keeping those boundaries visible lets readers use several resources without mistaking an educational research path for an automated prescription recommendation.

Put the research to use

Compare the exact product and the care process, then bring unresolved questions to the clinician. No route is a universal best option and this guide does not provide a switching prescription.

• Oral TRT product comparison
• SERM evidence versus testosterone replacement
• Compare actual quotes
• TRT research guide

Frequently asked questions

Is testosterone cream the same as gel?

Not necessarily. A compounded cream and an approved gel may differ in preparation, supporting evidence and instructions. The exact finished product matters more than the informal category name.

Can testosterone gel be applied to the scrotum?

The two gel labels cited here exclude genital application. Do not copy instructions for a different compounded formulation onto these products; resolve any conflicting instructions with the pharmacist or prescriber.

How long after testosterone gel can I shower?

Use the exact product instructions. The two cited labels illustrate different intervals: two hours for AndroGel 1.62% and five hours for the identified 1% product. This is not a rule for all gels or creams.

Do pellets keep testosterone perfectly stable?

The evidence reviewed does not support a promise of perfectly flat levels or no end-of-interval change. Discuss procedure risks, expected duration and adjustment options with the treating clinician.

Does choosing oral or topical TRT avoid fertility concerns?

A delivery route does not by itself resolve reproductive effects of exogenous testosterone. Discuss fertility goals before treatment; the guideline and product sources above explain why this matters.